GALENA BIOPHARMA
Galena Biopharma, Inc. (Galena) is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). In January 2014, Galena Biopharma Inc acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide.
GALENA BIOPHARMA
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2003-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.galenabiopharma.com
Total Employee:
51+
Status:
Active
Contact:
+118558554253
Email Addresses:
[email protected]
Total Funding:
33.1 M USD
Technology used in webpage:
Google Analytics Apache Google Analytics Classic Unified Layer CentOS Apache 2.2 BlueHost
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-14 | SELLAS Life Sciences | SELLAS Life Sciences acquired by Galena Biopharma | N/A |
Official Site Inspections
http://www.galenabiopharma.com
- Host name: 104.21.71.132
- IP address: 104.21.71.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Galena Biopharma"
SELLAS Life Sciences Group - Crunchbase Company Profile
Galena Biopharma, Inc. (Galena) is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted …See details»
Galena Biopharma Enters into Merger Agreement with SELLAS Life …
Aug 8, 2017 About Galena Biopharma Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs. …See details»
galenabiopharma.com
Galenabiopharma.comSee details»
Galena Biopharma Company Profile 2024: Valuation, …
Galena Biopharma General Information Description. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the …See details»
SELLAS Life Sciences Group Successfully Completes Business …
Dec 29, 2017 SELLAS Expected to Commence Trading on the Nasdaq Capital Market under Ticker Symbol “SLS” on January 2, 2018. HAMILTON, Bermuda and NEW YORK, Dec. 29, …See details»
Organization | Galena Biopharma, Inc.
Galena Biopharma, Inc. Report issue. For profit Phase 2 Phase 3. Founded: San Ramon CA United States ... Organization Overview. First Clinical Trial. 2011 NCT01479244. First …See details»
What You Need To Know About Galena Biopharma Inc (GALE) …
Aug 9, 2017 Out of the 4 analysts polled in the past 12 months, 3 rate Galena Biopharma stock a Hold, while 1 rates the stock a Buy. With a return potential of 945.8%, the stock's consensus …See details»
GALENA BIOPHARMA INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GALENA BIOPHARMA INC of Portland, OR. Get the latest business insights from Dun & Bradstreet.See details»
Galena Biopharma - The Org
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.See details»
Galena Biopharma Company Profile - Office Locations ... - Craft
See insights on Galena Biopharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Galena Biopharma merges SELLAS to form new combined company
Aug 9, 2017 Galena Biopharma’s lead immunotherapy programme, NeuVax (nelipepimut-S), is undergoing three Phase II investigator-sponsored clinical trials in breast cancer. The …See details»
Galena Biopharma Provides Corporate Update - GlobeNewswire
Jul 12, 2017 Source: Galena Biopharma, Inc. Contact Data Contact: Remy Bernarda SVP, Investor Relations & Corporate Communications (925) 498-7709 [email protected]See details»
Company Update (NASDAQ:GALE): Galena Biopharma Inc Shares …
Dec 29, 2017 Galena Biopharma Inc (NASDAQ:GALE) investors have sent shares flying almost 17% this morning following the drug maker's buzz-worthy news: shareholders said yes to …See details»
SELLAS Life Sciences Announces Final Court Approval of …
Feb 28, 2022 – Marks an End to All Litigation Related to Activities of SELLAS’ Predecessor, Galena Biopharma – NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) - SELLAS Life …See details»
Galena Biopharma - Recent News & Activity - Crunchbase
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.See details»
Galena Biopharma, Inc. | Insights
Feb 6, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Here’s Why Galena Biopharma Inc (GALE) Shares Popped Today
Sep 28, 2017 The milestones were reported by the clinical research organization conducting both trials – a Phase 2b clinical trial in HER2 1+/2+ patients and a Phase 2 clinical trial in …See details»
Galena Biopharma Inc. - The New York Times
News about Galena Biopharma Inc., including commentary and archival articles published in The New York Times.See details»
Galena Biopharma - 16 Year Stock Price History | SLS
Historical daily share price chart and data for Galena Biopharma since 2008 adjusted for splits and dividends. The latest closing stock price for Galena Biopharma as of December 05, 2024 …See details»